Kamada Ltd. (KMDA)
NGS · Common · CUSIP M6240T109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for KMDA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M6240T109
Market Cap
Small Cap · $235 Million
IPO
5/30/2013 · $9.25/share
Business: Kamada Ltd. is an Israel-based biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology. Kamada´s product line consists of more than 10 injectable pharmaceutical products which are marketed in more than 15 countries worldwide. The Company's pharmaceuticals are produced in its state-of-the-art, cGMP-compliant, FDA-approved, large scale production facility.

Company Contact

CEO
Amir London
CFO
Chaime Orlev
Investor Relations
Bob Yedid, LifeSci Advisors · 646-597-6989 · bob@lifesciadvisors.com
General Email
ir@kamada.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »